Tue. 9 Apr 2024, 9:41am ET
Benzinga
Biotech, News, Events, General
Compelling Data Validates the Potential of Reqorsa® Immunogene Therapy and the Oncoprex® Delivery System as Innovative Cancer Treatments
REQORSA Has Anti-Tumor Mechanisms and Ability to Trigger Cancer Cell Death